Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration
CONCLUSIONS AND RELEVANCE: In this case-control study of patients with hematologic cancers, odds of severe COVID-19 remained high through mid-2022 despite vaccination, especially in patients requiring treatment.PMID:38393725 | DOI:10.1001/jamanetworkopen.2024.0288
Source: Cancer Control - Category: Cancer & Oncology Authors: Sonia T Anand Austin D Vo Jennifer La Nhan V Do Nathanael R Fillmore Mary Brophy Westyn Branch-Elliman Paul A Monach Source Type: research
More News: Alzheimer's | Cancer | Cancer & Oncology | Cancer Vaccines | Cardiology | Chronic Kidney Disease | Chronic Obstructive Pulmonary | Covid Vaccine | COVID-19 | Dementia | Dexamethasone | Diabetes | Endemics | Endocrinology | Heart | Heart Failure | Hematology | Oral Cancer | Peripheral Vascular Disease (PVD) | SARS | Study | Urology & Nephrology | Vaccines